These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25156227)

  • 1. Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.
    Hermanstyne KA; Santos GM; Vittinghoff E; Santos D; Colfax G; Coffin P
    Drug Alcohol Depend; 2014 Oct; 143():277-80. PubMed ID: 25156227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine to reduce methamphetamine use: a randomized controlled trial.
    Colfax GN; Santos GM; Das M; Santos DM; Matheson T; Gasper J; Shoptaw S; Vittinghoff E
    Arch Gen Psychiatry; 2011 Nov; 68(11):1168-75. PubMed ID: 22065532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men.
    Das M; Santos D; Matheson T; Santos GM; Chu P; Vittinghoff E; Shoptaw S; Colfax GN
    AIDS; 2010 Apr; 24(7):991-1000. PubMed ID: 20397286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.
    McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BT; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M
    Trials; 2024 Jun; 25(1):408. PubMed ID: 38907288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial.
    Moore DJ; Pasipanodya EC; Umlauf A; Rooney AS; Gouaux B; Depp CA; Atkinson JH; Montoya JL
    Drug Alcohol Depend; 2018 Aug; 189():154-160. PubMed ID: 29958127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Coffin PO; Santos GM; Das M; Santos DM; Huffaker S; Matheson T; Gasper J; Vittinghoff E; Colfax GN
    Addiction; 2013 Apr; 108(4):751-61. PubMed ID: 23186131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence.
    Heinzerling KG; Gadzhyan J; van Oudheusden H; Rodriguez F; McCracken J; Shoptaw S
    J Adolesc Health; 2013 Apr; 52(4):502-5. PubMed ID: 23333007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability.
    Walker R; Hillhouse M; Perrochet B; Sparenborg S; Mooney L; Ling W
    J Addict Med; 2019; 13(5):372-378. PubMed ID: 30724759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.
    Starks TJ; Millar BM; Lassiter JM; Parsons JT
    AIDS Patient Care STDS; 2017 Feb; 31(2):78-86. PubMed ID: 28092450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
    Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
    AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.
    Parsons JT; Kowalczyk WJ; Botsko M; Tomassilli J; Golub SA
    AIDS Behav; 2013 May; 17(4):1478-87. PubMed ID: 23553345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use.
    Heinzerling KG; Swanson AN; Hall TM; Yi Y; Wu Y; Shoptaw SJ
    Addiction; 2014 Nov; 109(11):1878-86. PubMed ID: 24894963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephones.
    Galloway GP; Coyle JR; Guillén JE; Flower K; Mendelson JE
    J Addict Med; 2011 Sep; 5(3):170-4. PubMed ID: 21844832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users.
    Carrico AW; Johnson MO; Colfax GN; Moskowitz JT
    AIDS Behav; 2010 Aug; 14(4):769-77. PubMed ID: 19125321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.
    Dean AC; London ED; Sugar CA; Kitchen CM; Swanson AN; Heinzerling KG; Kalechstein AD; Shoptaw S
    Drug Alcohol Depend; 2009 Nov; 105(1-2):48-55. PubMed ID: 19608354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.